| Roche Pharma (Schweiz) AG - Actemra 162 mg/0.9 ml, Injektionslösung zur subkutanen Anwendung |
| 63166 | | 01 | | Actemra 162 mg/0.9 ml | | Injektionslösung zur subkutanen Anwendung | | L04AC07 | | Tocilizumab | | 12.09.2014 | | |
|
| Composition |
| tocilizumabum 162 mg, polysorbatum 80, arginini hydrochloridum, methioninum, histidinum, histidini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml. |
| Packungsbestandteile |
| Injektionslösung zur subkutanen Anwendung | | | | | | | | Active Agent | Dose |
|---|
| Tocilizumabum | 162mg / 0.9ml |
| | BAG: Active Agent | Dose |
|---|
| Tocilizumabum | 162 mg |
| | | | Inactive agents |
|---|
| Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Methionine | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 4 Fertigspritze(n) | 962.96 | 1063.70 | A | SL | No |
|
